Listen Now

Topics Covered

  • Overview of Triple Negative Breast Cancer
  • Triple Negative Breast Cancer and African American Women
  • Current Standard of Care
  • New Treatment Approaches
  • Clinical Trials: How Research Contributes to Your Treatment Options
  • Managing Side Effects, Neuropathy & Pain
  • Follow-Up Care Plan
  • Communicating with Your Health Care Team
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

Edith P. Mitchell, MD, FACP

Clinical Professor of Medicine and Medical Oncology, Program Leader, Gastrointestinal Oncology, Department of Medical Oncology, Director, Center to Eliminate Cancer Disparities, Associate Director, Diversity Affairs, Sidney Kimmel Cancer Center at Jefferson, President, National Medical Association

Lisa A. Newman, MD, MPH, FACS

Director of the Breast Oncology Program for the multi-hospital Henry Ford Health System (HFHS) and Founding Medical Director for the HFHS International Center for the Study of Breast Cancer Subtypes

Shannon Puhalla, MD

Director, Breast Cancer Clinical Research Program, Magee Women’s Hospital of UPMC, Women’s Cancer Center, Assistant Professor of Medicine, University of Pittsburgh School of Medicine

Hayley Dinerman, JD

Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation

Karen E. Jackson

Founder and CEO, Sisters Network® Inc. – A National African American Breast Cancer Survivorship Organization

Stacy Chilton, MSW, ACHP-SW

Women’s Cancers Program Coordinator, CancerCare


You can download the brochure for this workshop(pdf)(181 KB)

Workshop Date

This workshop was originally recorded on July 20, 2016.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top